Patent Assignment
Reel/Frame 054363/0516
Change of Name
Recorded: 2020-11-09
Pages: 4
Assignor
PRESBYOPIA THERAPIES, LLC
Executed: 2020-10-28
Assignee
PRESBYOPIA THERAPIES, INC.
915 OCEAN BLVD., CORONADO, CALIFORNIA, 92118
Covered Properties
(40)
Compositions and Methods for the Treatment of Presbyopia
Application:
61/871,215 →
Compositions and Methods for the Treatment of Presbyopia
Application:
61/882,998 →
Compositions and Methods for the Treatment of Presbyopia
Application:
61/904,510 →
Compositions and Methods for the Treatment of Presbyopia
Application:
61/917,620 →
Compositions and Methods for the Treatment of Presbyopia
Application:
61/938,438 →
Methods for the Treatment of Myopia
Application:
16/738,686 →
Methods for the Treatment of Myopia
Compositions and Methods for the Treatment of Presbyopia
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Application:
16/385,107 →
Publication:
US 2019/0240152
Compositions and Methods for the Treatment of Presbyopia
Application:
15/956,936 →
Publication:
US 2018/0235946
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Application:
16/156,276 →
Publication:
US 2019/0038609
Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
Application:
62/775,425 →
Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof
Compositions and Methods for the Treatment of Presbyopia
Application:
62/659,771 →
Compositions and Methods for the Treatment of Presbyopia
Application:
16/386,631 →
Publication:
US 2019/0321334
Aceclidine Isomers and Scalemic Mixtures Thereof for the Treatment of Presbyopia
Application:
62/720,421 →
Aceclidine Isomers and Scalemic Mixtures Thereof for the Treatment of Presbyopia
Application:
16/543,835 →
Publication:
US 2020/0061036
Compositions and Methods for the Treatment of Presbyopia
Application:
62/743,720 →
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Contact Lens Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye
Compositions and Methods for the Treatment of Presbyopia
Compositions and Methods for the Treatment of Presbyopia
Patent:
10,064,818 →
Application:
14/860,777 →
Publication:
US 2016/0008278
PCT:
PCT/US2014/052256 ↗
Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye
PCT:
PCT/US2016/036687 ↗
Compositions and Methods for the Treatment of Presbyopia
PCT:
PCT/US2017/021244 ↗
Contact Lens Compositions and Methods for the Treatment of Presbyopia
PCT:
PCT/US2018/066718 ↗
Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye
PCT:
PCT/US2016/036692 ↗
Compositions and Methods for the Treatment of Presbyopia
PCT:
PCT/US2016/036694 ↗
Prodrugs of Quinuclidine Ring-Containing Muscarinic Agonists and Compositions and Methods Thereof
PCT:
PCT/US2019/063923 ↗
Compositions and Methods for the Treatment of Presbyopia
PCT:
PCT/US2019/027819 ↗
Compositions and Methods for the Treatment of Presbyopia
PCT:
PCT/US2019/055116 ↗
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 23, 2013
From: HORN, GERALD; NORDAN, LEE
To: GNT LLC.
Reel/Frame 031465/0298 →
Assignment of Assignor's Interest
Oct 23, 2013
From: GNT LLC.
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 031465/0328 →
Assignment of Assignor's Interest
Mar 25, 2014
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 032516/0897 →
Assignment of Assignor's Interest
Nov 10, 2015
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 037001/0001 →
Assignment of Assignor's Interest
Mar 6, 2020
From: HORN, GERALD
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 052042/0121 →
Assignment of Assignor's Interest
May 26, 2020
From: AYOUB, MIMOUN; CORDEN PHARMA SWITZERLAND LLC
To: CORDEN PHARMA SWITZERLAND LLC; NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 052747/0307 →
Assignment of Assignor's Interest
May 28, 2020
From: MIMOUN, AYOUB
To: CORDEN PHARMA SWITZERLAND LLC
Reel/Frame 052776/0877 →
Assignment of Assignor's Interest
Jun 5, 2020
From: HORN, GERALD; NORDAN, LEE
To: PRESBYOPIA THERAPIES, LLC
Reel/Frame 052849/0632 →
Assignment of Assignor's Interest
Jun 11, 2020
From: HORN, GERALD
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 052909/0608 →
Merger and Change of Name
Sep 29, 2021
From: PRESBYOPIA THERAPIES, INC.; PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 057671/0014 →
Change of Name
Dec 15, 2022
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 062138/0206 →
Change of Name
Dec 15, 2022
From: PRESBYOPIA THERAPIES, LLC
To: PRESBYOPIA THERAPIES, INC.
Reel/Frame 062138/0292 →
Assignment of Assignor's Interest
Dec 20, 2023
From: HORN, GERALD
To: PRESBYOPIA THERAPIES LLC
Reel/Frame 065920/0248 →
Change of Name
Apr 2, 2024
From: LENZ THERAPEUTICS, INC.
To: LENZ THERAPEUTICS OPERATIONS, INC.
Reel/Frame 066978/0082 →
Change of Name
Apr 3, 2024
From: PRESBYOPIA THERAPIES, INC.
To: LENZ THERAPEUTICS, INC.
Reel/Frame 067002/0157 →
Change of Name
Apr 8, 2024
From: LENZ THERAPEUTICS, INC.
To: LENZ THERAPEUTICS OPERATIONS, INC.
Reel/Frame 067625/0816 →